IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:IPN - FR0010259150 - Common Stock
121.9 EUR
-0.5 (-0.41%)
IPN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. IPN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IPN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IPN was profitable.
In the past year IPN had a positive cash flow from operations.
IPN had positive earnings in each of the past 5 years.
Each year in the past 5 years IPN had a positive operating cash flow.
1.2 Ratios
IPN has a Return On Assets of 6.56%. This is comparable to the rest of the industry: IPN outperforms 58.18% of its industry peers.
With a Return On Equity value of 10.59%, IPN perfoms like the industry average, outperforming 52.73% of the companies in the same industry.
With a decent Return On Invested Capital value of 14.88%, IPN is doing good in the industry, outperforming 76.36% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IPN is in line with the industry average of 13.92%.
The 3 year average ROIC (12.97%) for IPN is below the current ROIC(14.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
IPN's Profit Margin of 11.91% is in line compared to the rest of the industry. IPN outperforms 49.09% of its industry peers.
In the last couple of years the Profit Margin of IPN has declined.
IPN has a better Operating Margin (26.01%) than 61.82% of its industry peers.
In the last couple of years the Operating Margin of IPN has declined.
The Gross Margin of IPN (83.32%) is better than 89.09% of its industry peers.
IPN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
IPN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
IPN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for IPN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, IPN has an improved debt to assets ratio.
2.2 Solvency
IPN has an Altman-Z score of 4.49. This indicates that IPN is financially healthy and has little risk of bankruptcy at the moment.
IPN's Altman-Z score of 4.49 is fine compared to the rest of the industry. IPN outperforms 69.09% of its industry peers.
IPN has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
The Debt to FCF ratio of IPN (1.69) is better than 90.91% of its industry peers.
IPN has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
IPN has a Debt to Equity ratio of 0.20. This is in the better half of the industry: IPN outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.49 |
ROIC/WACC1.91
WACC7.8%
2.3 Liquidity
A Current Ratio of 1.98 indicates that IPN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.98, IPN is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
A Quick Ratio of 1.80 indicates that IPN should not have too much problems paying its short term obligations.
The Quick ratio of IPN (1.80) is better than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.24% over the past year.
Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
Looking at the last year, IPN shows a quite strong growth in Revenue. The Revenue has grown by 9.45% in the last year.
Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
IPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.58% yearly.
IPN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.58% yearly.
EPS Next Y6.71%
EPS Next 2Y3.8%
EPS Next 3Y4.44%
EPS Next 5Y5.58%
Revenue Next Year8.23%
Revenue Next 2Y6.1%
Revenue Next 3Y6%
Revenue Next 5Y4.58%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 11.87, the valuation of IPN can be described as reasonable.
IPN's Price/Earnings ratio is a bit cheaper when compared to the industry. IPN is cheaper than 74.55% of the companies in the same industry.
When comparing the Price/Earnings ratio of IPN to the average of the S&P500 Index (26.46), we can say IPN is valued rather cheaply.
A Price/Forward Earnings ratio of 11.02 indicates a reasonable valuation of IPN.
Based on the Price/Forward Earnings ratio, IPN is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of IPN to the average of the S&P500 Index (36.10), we can say IPN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.87 | ||
| Fwd PE | 11.02 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IPN is valued cheaply inside the industry as 96.36% of the companies are valued more expensively.
63.64% of the companies in the same industry are more expensive than IPN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.81 | ||
| EV/EBITDA | 5.78 |
4.3 Compensation for Growth
IPN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of IPN may justify a higher PE ratio.
PEG (NY)1.77
PEG (5Y)1.35
EPS Next 2Y3.8%
EPS Next 3Y4.44%
5. Dividend
5.1 Amount
IPN has a Yearly Dividend Yield of 1.14%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.86, IPN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, IPN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.14% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
IPN pays out 25.90% of its income as dividend. This is a sustainable payout ratio.
IPN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP25.9%
EPS Next 2Y3.8%
EPS Next 3Y4.44%
EPA:IPN (12/5/2025, 7:00:00 PM)
121.9
-0.5 (-0.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners15.21%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap10.22B
Revenue(TTM)3.76B
Net Income(TTM)447.90M
Analysts68.89
Price Target131.89 (8.2%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.14% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.99%
PT rev (3m)2.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.44%
EPS NY rev (3m)5.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)1.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.87 | ||
| Fwd PE | 11.02 | ||
| P/S | 2.72 | ||
| P/FCF | 19.81 | ||
| P/OCF | 11.39 | ||
| P/B | 2.42 | ||
| P/tB | 7.65 | ||
| EV/EBITDA | 5.78 |
EPS(TTM)10.27
EY8.42%
EPS(NY)11.07
Fwd EY9.08%
FCF(TTM)6.15
FCFY5.05%
OCF(TTM)10.71
OCFY8.78%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.77
PEG (5Y)1.35
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.49 |
F-Score7
WACC7.8%
ROIC/WACC1.91
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y6.71%
EPS Next 2Y3.8%
EPS Next 3Y4.44%
EPS Next 5Y5.58%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.23%
Revenue Next 2Y6.1%
Revenue Next 3Y6%
Revenue Next 5Y4.58%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year32.82%
EBIT Next 3Y13.53%
EBIT Next 5Y7.89%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
Can you provide the valuation status for IPSEN?
ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the earnings growth outlook for IPSEN?
The Earnings per Share (EPS) of IPSEN (IPN.PA) is expected to grow by 6.71% in the next year.
Can you provide the dividend sustainability for IPN stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.9%.